Thryv Therapeutics Inc

Giiant Pharma Inc. is a Montréal-based company specializing in the healthcare sector, showcasing a commitment to innovative solutions in pharmaceuticals. They focus on delivering quality products that meet the diverse needs of their clients and stakeholders. The company aims to enhance health outcomes through research and development, ensuring they stay at the forefront of industry advancements. With a dedication to excellence, Giiant Pharma Inc. continues to invest in its team's expertise and technological capabilities. Generated from the website

Inversago Pharma Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing innovative treatments for patients suffering from metabolic and fibrotic diseases. The company is at the forefront of developing therapies that target the inhibition of peripheral CB1 receptors to alleviate complications associated with metabolic disorders. The company's primary program, INV202, is currently undergoing Phase 2 studies for treating diabetes and associated conditions. Inversago Pharma aims to advance its pipeline of CB1 receptor inhibitors to improve the quality of life for patients affected by various metabolic diseases, including type 1 and type 2 diabetes, non-alcoholic fatty liver disease, and fibrotic diseases. Generated from the website

Angiochem Inc is a biotechnology company based in Montréal, QC, specializing in the development of novel peptide-drug conjugates for the treatment of neurological diseases and disorders. The company's research focuses on utilizing its proprietary platform technology to create innovative therapies that target the blood-brain barrier to deliver drugs directly to the central nervous system. Generated from their business information